Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112

Código QR

Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112

Dong Dong,1* Xiao Wang,1* Huailing Wang,1 Xingwang Zhang,2 Yifei Wang,1 Baojian Wu2 1Guangzhou Jinan Biomedicine Research and Development Center, 2Division of Pharmaceutics, College of Pharmacy, Jinan University, Guangzhou, People’s Republic of China *These authors contributed equally t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dong D, Wang X, Wang H, Zhang X, Wang Y, Wu B
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/5f7e61c6a9d94932aa455c3f25ca5f5c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Acta N°2112
por: Banco Central de Chile
Publicado: (2021)

Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo
por: Wu X, et al.
Publicado: (2014)

Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery
por: Li Y, et al.
Publicado: (2017)

The SNX-PX-BAR family in macropinocytosis: the regulation of macropinosome formation by SNX-PX-BAR proteins.
por: Jack T H Wang, et al.
Publicado: (2010)

Systemic delivery of the anticancer agent arenobufagin using polymeric nanomicelles
por: Yuan X, et al.
Publicado: (2017)

In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes
por: Chen M, et al.
Publicado: (2017)

Pharmacokinetics of peptide mediated delivery of anticancer drug ellipticine.
por: Weina Ma, et al.
Publicado: (2012)

Pharmacokinetics of quercetin-loaded nanodroplets with ultrasound activation and their use for bioimaging
por: Chang LW, et al.
Publicado: (2015)

Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis
por: Yang X, et al.
Publicado: (2015)

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
por: Denise A. Cobb, et al.
Publicado: (2021)

Sustained delivery of a camptothecin prodrug – CZ48 by nanosuspensions with improved pharmacokinetics and enhanced anticancer activity
por: Dong D, et al.
Publicado: (2019)

Regulation of the endosomal SNX27-retromer by OTULIN
por: Aurelia Stangl, et al.
Publicado: (2019)

The physical properties of (As2Se3)1-x:Snx and (As4S3Se3)1-x:Snx glasses
por: Iaseniuc, Oxana, et al.
Publicado: (2013)

Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro
por: Qin F, et al.
Publicado: (2015)

In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer
por: Lawal B, et al.
Publicado: (2021)

Unstable twin in body-centered cubic tungsten nanocrystals
por: Xiang Wang, et al.
Publicado: (2020)

Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
por: Nagsen Gautam, et al.
Publicado: (2021)

Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
por: Edis Z, et al.
Publicado: (2021)

Effect of particle size on oral absorption of carvedilol nanosuspensions: in vitro and in vivo evaluation
por: Liu DD, et al.
Publicado: (2015)

Large nonlinear dielectric behavior in BaTi1−xSnxO3
por: Pengrong Ren, et al.
Publicado: (2017)

Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases
por: Muhammad F. Rasool, et al.
Publicado: (2021)

pH-dependent and cathepsin B activable CaCO3 nanoprobe for targeted in vivo tumor imaging
por: Sun N, et al.
Publicado: (2019)

The cryo-EM structure of the SNX–BAR Mvp1 tetramer
por: Dapeng Sun, et al.
Publicado: (2020)

SNX10 gene mutation leading to osteopetrosis with dysfunctional osteoclasts
por: Eva-Lena Stattin, et al.
Publicado: (2017)

Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]
por: Edis Z, et al.
Publicado: (2021)

PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
por: Yi Zhao, et al.
Publicado: (2016)

Application of Physiologically Based Pharmacokinetic Modeling to Evaluate the Drug–Drug and Drug–Disease Interactions of Apatinib
por: Hongrui Liu, et al.
Publicado: (2021)

A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics
por: Yating Zhao, et al.
Publicado: (2017)

Mixed nanomicelles as potential carriers for systemic delivery of Z-GP-Dox, an FAPα-based doxorubicin prodrug: formulation and pharmacokinetic evaluation
por: Zhang Y, et al.
Publicado: (2015)

Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin
por: Zhang KC, et al.
Publicado: (2013)

INDOLE DERIVATIVES AS POTENTIAL ANTICANCER AGENTS: A REVIEW
por: Sachdeva,Harshita, et al.
Publicado: (2020)

Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
por: Ververis K, et al.
Publicado: (2013)

Crystal structure elucidation and anticancer studies of (-)-pseudosemiglabrin: a flavanone isolated from the aerial parts of Tephrosia apollinea.
por: Loiy Elsir Ahmed Hassan, et al.
Publicado: (2014)

RAMAN CHARACTERIZATION OF CuCr2-xSnxS4 SPINELS
por: Valencia-Gálvez,P., et al.
Publicado: (2019)

SNX19 restricts endolysosome motility through contacts with the endoplasmic reticulum
por: Amra Saric, et al.
Publicado: (2021)

YAP determines the cell fate of injured mouse hepatocytes in vivo
por: Norio Miyamura, et al.
Publicado: (2017)

The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development
por: Cvijić Sandra, et al.
Publicado: (2021)

Prospects and limitations of physiologically-based pharmacokinetic modelling for cross-species extrapolation
por: Lars Kuepfer
Publicado: (2019)

A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles
por: Bachler G, et al.
Publicado: (2013)

In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery
por: Xu H, et al.
Publicado: (2021)